Purehealth, the Middle East’s largest healthcare group, reported revenue of AED7.3 billion for the first quarter of 2026, marking a 10 percent year-on-year increase as demand for healthcare services remains resilient across both domestic and international markets.
The Abu Dhabi-based group’s performance was underpinned by strong growth in its Care (healthcare) and Cover (insurance) verticals, as well as contributions from its expanding international portfolio. The results reflect a broader trend in the UAE’s healthcare sector, where rising population demand, insurance penetration, and medical tourism continue to support long-term growth.
Earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 5 percent year-on-year to AED1.2 billion, highlighting operational stability even as the company scales globally. However, net profit for the quarter came in at AED415 million, with the group citing regulatory changes under the Unified Purchasing Program (UPP) as a key factor affecting profitability.
“PureHealth delivered a strong start to 2026, with robust growth across the Group reflecting sustained demand and disciplined execution. Our performance continues to be driven by the scale and resilience of our integrated Care and Cover model, which provides both stability and long-term growth opportunities,” said Kamal Al Maazmi, Chairman of PureHealth.
“The continued momentum in our international portfolio has played an increasingly important role in the Group’s growth and diversification, while complementing our leadership position in the UAE. As we move forward, we remain focused on advancing our strategy and reinforcing PureHealth’s position as a leading global healthcare platform.”
The group’s global ambitions were further emphasized by its leadership, with recent acquisitions continuing to scale. “Our first-quarter performance reflects resilience across our core markets and the growing momentum of our international portfolio. Circle Health and Hellenic Healthcare Group delivered solid performances, significantly scaling our international revenue base and further reinforcing the strategic rationale for our global expansion,” said Shaista Asif, Group Chief Executive Officer.
“In the UAE, we continued to expand capacity, deepen clinical complexity, and grow our insurance platform, reflecting the sustained underlying strength of our home market.”
From a regional perspective, PureHealth’s results align with Abu Dhabi’s broader strategy to position itself as a global healthcare hub, supported by investments in infrastructure, advanced treatments, and digital health technologies. The group’s integrated Care and Cover model also reflects a structural shift in the sector, where providers are increasingly combining healthcare delivery with insurance to improve margins and patient outcomes.
Looking ahead, PureHealth expects its high-margin international portfolio to play a larger role in revenue growth, with recently acquired assets contributing to scale and operational efficiency. The company is also continuing to invest in capacity expansion, specialized care, and AI-driven technologies to improve efficiency and the patient experience.
While regulatory changes such as the UPP may continue to influence short-term profitability, the underlying fundamentals of the UAE healthcare market remain strong, supported by demographics, policy support, and rising demand for high-quality care.
With inputs from WAM
